Division of Neurosurgery, State University of New York at Stony Brook, Stony Brook, New York 11794–8121, USA.
J Neurointerv Surg. 2009 Jul;1(1):56-65. doi: 10.1136/jnis.2009.000083. Epub 2009 Jun 16.
Endovascular, endosaccular, coil embolization has emerged as an established therapy for both ruptured and unruptured cerebral aneurysms. However, many aneurysms are not cured using conventional endovascular techniques. Coil embolization often results in incomplete aneurysm occlusion or recanalization in the ensuing months after treatment. The Pipeline embolization device (PED; Chestnut Medical) represents a new generation endoluminal implant which is designed to treat aneurysms by reconstructing the diseased parent artery. Immediately after implantation, the PED functions to divert flow from the aneurysm, creating an environment conducive to thrombosis. With time, the PED is incorporated into the vessel wall as neointimal-endothelial overgrowth occurs along the construct. Ultimately, this process results in the durable complete exclusion of the aneurysm from the cerebrovasculature and a definitive endoluminal reconstruction of the diseased parent artery.
血管内、囊内、线圈栓塞已经成为破裂和未破裂脑动脉瘤的一种既定治疗方法。然而,许多动脉瘤不能用传统的血管内技术治愈。线圈栓塞治疗后,在随后的几个月中常导致不完全的动脉瘤闭塞或再通。Pipeline 栓塞装置(PED;Chestnut Medical)代表了新一代的腔内植入物,旨在通过重建病变的母动脉来治疗动脉瘤。植入后,PED 立即起作用,将血流从动脉瘤中分流出来,创造一个有利于血栓形成的环境。随着时间的推移,PED 被整合到血管壁中,因为沿着构建物发生新生内膜-内皮过度生长。最终,这个过程导致动脉瘤从脑血管中持久完全排除,并对病变的母动脉进行确定性的腔内重建。